Understanding the impact of the Israeli-U.S. attacks on Iran’s nuclear facilities

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Unless you were sleeping under a rock, you are aware of the coordinated attacks on Iran’s nuclear facilities by Israel and the United States. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Robert Peter Gale, MD, PhD, DSc (hon), FACP, FRCP, FRCPI(hon), FRSM
Visiting professor, Centre for Haematology, Department of Immunology and Inflammation, Imperial College of Science, Technology and Medicine, London; Honorary professor, Institute of Hematology, Chinese Academy of Medical Sciences and Peking Union Medical College; Visiting professor, Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
Table of Contents

YOU MAY BE INTERESTED IN

KRAS is the most frequently mutated oncogene across all human cancers. Although different KRAS mutations have long been thought to exert the same cancer-driving effects, a new study led by UT Southwestern Medical Center researchers suggests that different KRAS mutation types can variously impact how cancer cells interact with immune cells, significantly affecting the malignant cells’ behavior. 
Robert Peter Gale, MD, PhD, DSc (hon), FACP, FRCP, FRCPI(hon), FRSM
Visiting professor, Centre for Haematology, Department of Immunology and Inflammation, Imperial College of Science, Technology and Medicine, London; Honorary professor, Institute of Hematology, Chinese Academy of Medical Sciences and Peking Union Medical College; Visiting professor, Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login